Danish dogs to receive virus-inspired cancer vaccine treatment

Researchers are testing the therapeutic vaccine on dogs with the hope that trials could progress to humans. Image Credit - Pixabay/No License

Fifteen Danish dogs with advanced cancer are to receive a new type of therapeutic vaccine which, it is hoped, will rid them of the disease and pave the way for human testing. Unlike preventative vaccines, therapeutic vaccines are not used to prevent someone from getting a disease but rather to support an immune system that … Read more

In a picture: Hunting down guerrilla tumour cells – Prof. Rolf Bjerkvig

Brain tumours contain many different types of cells, here stained different colours, which makes them complex to treat.

Professor Rolf Bjerkvig, a specialist in brain cancer research, tells us why guerrilla cells make the disease so hard to treat. Brain tumours are hard to treat completely with surgery because they leave behind cells that invade the brain. In this video, which covers 72 hours, you can see cells breaking off from a tumour to invade other … Read more

Scientists can predict rare leukaemia 8 years before symptoms begin

Image Credit: National Cancer Institute

A study of more than half a million blood samples has allowed scientists to pinpoint the risk factors for a rare type of leukaemia, enabling them to predict if someone will develop the disease eight years before symptoms appear and opening the door to preventative treatments. Acute myeloid leukaemia (AML) is a rare cancer usually … Read more

Family’s grief sparks a quest for better bladder cancer cures

Millions of lives are lost to cancer due to late detection so scientists are working on better ways of diagnosing the disease.

‘Invasive and uncomfortable’ prodedures for detecting if someone has bladder cancer could be replaced by urine tests that not only screen for the presence of the disease but also help doctors choose the right course of treatment for a particular patient. ‘Our lives literally came to a stop when my mother was diagnosed with cancer,’ said … Read more

Europe is in danger of being out-innovated in regenerative medicine – Prof. Ton Rabelink

With the right environments, stem cells can potentially be reprogrammed to grow kidney tissue.

by Frieda Klotz Regenerative medicine should be governed, firstly, by the principle of do no harm, but a better balance between risk and regulation is required to bring innovations to market more quickly, according to Ton Rabelink, professor of internal medicine and head of nephrology at Leiden University in the Netherlands. He says that Europe is in … Read more